Cited by 810Cancer-related Molecular PathwaysCell death mechanisms and regulationGenomics and Chromatin Dynamics

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

p53 isoforms can regulate p53 transcriptional activity

Open access

Bourdon, Jean-Christophe, Fernandes, Kenneth, Murray-Zmijewski, Fiona, Liu, Geng, Diot, Alexandra, Xirodimas, Dimitris P., Saville, Mark K., Lane, David P.·2005·Genes & Development

DOI 10.1101/gad.1339905PMC PMC1221884

Open this paper in CoChat — free account Open PDF

Abstract

The recently discovered p53-related genes, p73 and p63, express multiple splice variants and N-terminally truncated forms initiated from an alternative promoter in intron 3. To date, no alternative promoter and multiple splice variants have been described for the p53 gene. In this study, we show that p53 has a gene structure similar to the p73 and p63 genes. The human p53 gene contains an alternative promoter and transcribes multiple splice variants. We show that p53 variants are expressed in normal human tissue in a tissue-dependent manner. We determine that the alternative promoter is conserved through evolution from Drosophila to man, suggesting that the p53 family gene structure plays an essential role in the multiple activities of the p53 family members. Consistent with this hypothesis, p53 variants are differentially expressed in human breast tumors compared with normal breast tissue. We establish that p53β can bind differentially to promoters and can enhance p53 target gene expression in a promoter-dependent manner, while Δ133p53 is dominant-negative toward full-length p53, inhibiting p53-mediated apoptosis. The differential expression of the p53 isoforms in human tumors may explain the difficulties in linking p53 status to the biological properties and drug sensitivity of human cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1101/gad.1339905

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,318
T antigen is bound to a host protein in SY40-transformed cells
Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456
Self-citation
Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814
p53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459
Decision making by p53: life, death and cancer
Oren, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401183 · Cited by 1,085
Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.
DeLeo, A. B., Jay, G. D., Appella, E., DuBois, G. C., Law, L. W., & Old, L. J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.5.2420 · Cited by 721
Modulation of mammalian life span by the short isoform of p53
Maier, B., Gluba, W., Bernier, B., Turner, T., Mohammad, K., Guise, T., Sutherland, A., Thorner, M., & Scrable, H. (2004) · Genes & Development · doi:10.1101/gad.1162404 · Cited by 586
Mdm2-Mediated NEDD8 Conjugation of p53 Inhibits Its Transcriptional Activity
Xirodimas, D. P., Saville, M. K., Bourdon, J.-C., Hay, R. T., & Lane, D. P. (2004) · Cell · doi:10.1016/j.cell.2004.06.016 · Cited by 570
Self-citation
On the shoulders of giants: p63, p73 and the rise of p53
Yang, A., Kaghad, M., Caput, D., & McKeon, F. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02595-7 · Cited by 496
Drosophila p53 Binds a Damage Response Element at the reaper Locus
Brodsky, M. H., Nordstrom, W., Tsang, G., Kwan, E., Rubin, G. M., & Abrams, J. (2000) · Cell · doi:10.1016/s0092-8674(00)80627-3 · Cited by 474

Show all 43 references

Research works printed but not linked: 7

1996, Oncogene, 12, 813
1986, Mol. Cell. Biol., 6, 1379
2003, Cell Death Differ., 1, 431
1995, Oncogene, 10, 1865
1995, Oncogene, 10, 389
1985, Mol. Cell. Biol., 5, 127
2003, Cancer Res., 63, 2351

Sorted by citations

Items 301–400 of 807

Functional characterization of a new p53 mutant generated by homozygous deletion in a neuroblastoma cell line
Nakamura, Y., Ozaki, T., Niizuma, H., Ohira, M., Kamijo, T., & Nakagawara, A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.057 · Cited by 40
Exploiting the p53 Pathway for the Diagnosis and Therapy of Human CancerPreprint
Lane, D. P. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.049 · Cited by 40
Self-citation
The Δ133p53 isoform and its mouse analogue Δ122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2
Roth, I. M., Campbell, H., Cortés-Rubio, C. N., Vennin, C., Wilson, M., Wiles, A. K., Williams, G., Woolley, A. G., Timpson, P., Berridge, M. V., et al. (2016) · Oncogene · doi:10.1038/onc.2016.45 · Cited by 39
Polo‐like kinase‐1 phosphorylates MDM2 at Ser260 and stimulates MDM2‐mediated p53 turnover
Dias, S. S., Hogan, C., Ochocka, A. M., & Meek, D. W. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.09.057 · Cited by 39
Aging-associated truncated form of p53 interacts with wild-type p53 and alters p53 stability, localization, and activity
Moore, L. M., Lu, X., Ghebranious, N., Tyner, S. D., & Donehower, L. A. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.10.011 · Cited by 38
DNA damage stress response in germ cells: role of c-Abl and clinical implications
Gonfloni, S. (2010) · Oncogene · doi:10.1038/onc.2010.410 · Cited by 39
Understanding the Multifaceted Role of Human Down Syndrome Kinase DYRK1A
Kay, L. J., Smulders-Srinivasan, T. K., & Soundararajan, M. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2016.07.001 · Cited by 37
Inhibition of nonsense-mediated decay rescues p53β/γ isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancers
Gudikote, J. P., Cascone, T., Poteete, A., Sitthideatphaiboon, P., Wu, Q., Morikawa, N., Zhang, F., Peng, S., Tong, P., Li, L., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101163 · Cited by 39
Self-citation
p53 Isoforms as Cancer Biomarkers and Therapeutic Targets
Zhao, L., & Sanyal, S. (2022) · Cancers · doi:10.3390/cancers14133145 · Cited by 42
Immunohistochemistry in diagnostic surgical pathology: contributions of protein life-cycle, use of evidence-based methods and data normalization on interpretation of immunohistochemical stains.
Idikio, H. (2009) · PubMed Central · Cited by 38
TAp63-dependent induction of growth differentiation factor 15 (GDF15) plays a critical role in the regulation of keratinocyte differentiation
Ichikawa, T., Suenaga, Y., Koda, T., Ozaki, T., & Nakagawara, A. (2007) · Oncogene · doi:10.1038/sj.onc.1210658 · Cited by 38
MicroRNA‐34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma
Toraih, E. A., Ibrahiem, A. T., Fawzy, M. S., Hussein, M. H., Alqahtani, S. A. M., & Shaalan, A. A. M. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3269379 · Cited by 38
p53 activation by knockdown technologies
Robu, M. E., Larson, J. D., Nasevicius, A., Beiraghi, S., Brenner, C., Farber, S. A., & Ekker, S. C. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0030078.eor · Cited by 37
The p53 isoforms are differentially modified by Mdm2
Camus, S., Ménendez, S., Fernandes, K., Kua, N., Liu, G., Xirodimas, D. P., Lane, D. P., & Bourdon, J. (2012) · Cell Cycle · doi:10.4161/cc.20119 · Cited by 35
Self-citation
Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer
Marabese, M., Marchini, S., Marrazzo, E., Mariani, P., Cattaneo, D., Fossati, R., Compagnoni, A., Signorelli, M., Moll, U. M., Codegoni, A. M., et al. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.10.011 · Cited by 37
Reassessing the role of p53 in cancer and ageing from an evolutionary perspective
Aranda-Anzaldo, A., & Dent, M. A. R. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.01.001 · Cited by 36
Recommendations for Analyzing and ReportingTP53Gene Variants in the High-Throughput Sequencing Era
Soussi, T., Leroy, B., & Taschner, P. E. M. (2014) · Human Mutation · doi:10.1002/humu.22561 · Cited by 37
Invertebrate p53-like mRNA isoforms are differentially expressed in mussel haemic neoplasia
Muttray, A. F., Schulte, P. M., & Baldwin, S. A. (2008) · Marine Environmental Research · doi:10.1016/j.marenvres.2008.06.004 · Cited by 36
Proteomic Characterization of Transcription and Splicing Factors Associated with a Metastatic Phenotype in Colorectal Cancer
Torres, S., García‐Palmero, I., Marín‐Vicente, C., Bartolomé, R. A., Calviño, E., Fernández‐Aceñero, M. J., & Casal, J. I. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00548 · Cited by 37
Dominant Effects of Δ40p53 on p53 Function and Melanoma Cell Fate
Takahashi, R., Markovic, S. N., & Scrable, H. J. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.391 · Cited by 36
Correction of a genetic defect in multipotent germline stem cells using a human artificial chromosome
Kazuki, Y., Hoshiya, H., Kai, Y., Abe, S., Takiguchi, M., Osaki, M., Kawazoe, S. K. Y., Katoh, M., Kanatsu‐Shinohara, M., Inoue, K., et al. (2008) · Gene Therapy · doi:10.1038/sj.gt.3303091 · Cited by 36
Expression analysis of the molluscan p53 protein family mRNA in mussels (Mytilus spp.) exposed to organic contaminants
Bannı, M., Negri, A., Rebelo, M. D. F., Rapallo, F., Boussetta, H., Viarengo, A., & Dondero, F. (2008) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2008.09.017 · Cited by 36
The anti-apoptotic factor Che-1/AATF links transcriptional regulation, cell cycle control, and DNA damage response
Passananti, C., & Fanciulli, M. (2007) · Cell Division · doi:10.1186/1747-1028-2-21 · Cited by 34
p53 isoform Δ133p53 promotes efficiency of induced pluripotent stem cells and ensures genomic integrity during reprogramming
Gong, L., Pan, X., Chen, H., Rao, L., Zeng, Y., Hang, H., Peng, J., Xiao, L., & Chen, J. (2016) · Scientific Reports · doi:10.1038/srep37281 · Cited by 37
Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation
Montano, X. (2009) · Oncogene · doi:10.1038/onc.2009.143 · Cited by 35
Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas
Chiang, M., Chou, P., Wang, W., Sze, C., & Chang, N. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00043 · Cited by 34
The C/H3 Domain of p300 Is Required to Protect VRK1 and VRK2 from their Downregulation Induced by p53
Valbuena, A., Blanco, S., Vega, F. M. D. L., & Lazo, P. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002649 · Cited by 34
Prognostic value of p53 mutations in oesophageal adenocarcinoma: final results of a 15-year prospective study
Madani, K., Zhao, R., Lim, H. J., & Casson, A. G. (2010) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2009.12.018 · Cited by 35
ΔNp63/BMP-7-dependent expression of matrilin-2 is involved in keratinocyte migration in response to wounding
Ichikawa, T., Suenaga, Y., Koda, T., Ozaki, T., & Nakagawara, A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.128 · Cited by 35
The Evolution of TP53 Mutations: From Loss-of-Function to Separation-of-Function Mutants.
Miller, M., Shirole, N. H., Tian, R., Pal, D., & Sordella, R. (2016) · PubMed · Cited by 35
A minimally invasive assay for individual assessment of the ATM/CHEK2/p53 pathway activity
Kabacik, S., Ortega-Molina, A., Efeyan, A., Finnon, P., Bouffler, S. D., Serrano, M., & Badie, C. (2011) · Cell Cycle · doi:10.4161/cc.10.7.15231 · Cited by 38
Control mechanisms in germ cells mediated by p53 family proteins
Gebel, J., Tuppi, M., Krauskopf, K., Coutandin, D., Pitzius, S., Kehrloesser, S., Osterburg, C., & Dötsch, V. (2017) · Journal of Cell Science · doi:10.1242/jcs.204859 · Cited by 33
Good Cop, Bad Cop: Defining the Roles of Δ40p53 in Cancer and Aging
Reinhardt, L. S., Zhang, X., Wawruszak, A., Groen, K., Iuliis, G. N. D., & Avery‐Kiejda, K. A. (2020) · Cancers · doi:10.3390/cancers12061659 · Cited by 33
The variation game: Cracking complex genetic disorders with NGS and omics data
Cui, H., Dhroso, A., Johnson, N. T., & Korkin, D. (2015) · Methods · doi:10.1016/j.ymeth.2015.04.018 · Cited by 36
Influenza A Viruses Control Expression of Proviral Human p53 Isoforms p53β and Δ133p53α
Terrier, O., Marcel, V., Cartet, G., Lane, D. P., Lina, B., Rosa‐Calatrava, M., & Bourdon, J. (2012) · Journal of Virology · doi:10.1128/jvi.07143-11 · Cited by 34
Self-citation
Direct Activation of Forkhead Box O3 by Tumor Suppressors p53 and p73 Is Disrupted During Liver Regeneration in Mice†,‡
Kurinna, S. M., Stratton, S. A., Tsai, W.-W., Akdemir, K. C., Gu, W., Singh, P., Goode, T., Darlington, G., & Barton, M. C. (2010) · Hepatology · doi:10.1002/hep.23746 · Cited by 34
Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma
Kawano, S. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1151 · Cited by 34
Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53null Cell Lines
Silden, E., Hjelle, S. M., Wergeland, L., Sulen, A., Andresen, V., Bourdon, J., Micklem, D., McCormack, E., & Gjertsen, B. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056276 · Cited by 33
Self-citation
Novel recurrent neural network for modelling biological networks: Oscillatory p53 interaction dynamics
Ling, H., Samarasinghe, S., & Kulasiri, D. (2013) · Biosystems · doi:10.1016/j.biosystems.2013.08.004 · Cited by 32
Identification of nonsense-mediated mRNA decay pathway as a critical regulator of p53 isoform β
Cowen, L. E., & Tang, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-17283-4 · Cited by 35
Δ133p53α, a natural p53 isoform, contributes to conditional reprogramming and long-term proliferation of primary epithelial cells
Mondal, A. M., Zhou, H., Horikawa, I., Suprynowicz, F. A., Li, G., Dakic, A., Rosenthal, B., Ye, L., Harris, C. C., Schlegel, R., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0767-7 · Cited by 33
The p53 Family: A Role in Lipid and Iron Metabolism
Laubach, K., Zhang, J., & Chen, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.715974 · Cited by 35
Δ133p53β isoform pro-invasive activity is regulated through an aggregation-dependent mechanism in cancer cells
Arsic, N., Slatter, T. L., Gadéa, G., Villain, É., Fournet, A., Kazantseva, M., Allemand, F., Sibille, N., Sevéno, M., de Rossi, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25550-2 · Cited by 33
Self-citation
Alternative Splicing in Cancer and Immune Cells
Bernard, A., Boidot, R., & Végran, F. (2022) · Cancers · doi:10.3390/cancers14071726 · Cited by 33
The Elephant Evolved p53 Isoforms that Escape MDM2-Mediated Repression and Cancer
Padariya, M., Jooste, M.-L., Hupp, T., Fåhraeus, R., Vojtesek, B., Vollrath, F., Kalathiya, U., & Karakostis, K. (2022) · Molecular Biology and Evolution · doi:10.1093/molbev/msac149 · Cited by 33
p53 Family in Resistance to Targeted Therapy of Melanoma
Vlašić, I., Horvat, A., Tadijan, A., & Slade, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010065 · Cited by 36
A role for p53 in mitochondrial stress response control of longevity in C. elegans
Torgovnick, A., Schiavi, A., Testi, R., & Ventura, N. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.02.007 · Cited by 33
The expression and significance of IDH1 and p53 in osteosarcoma
Hu, X., Yu, A., Qi, B., Fu, T., Wu, G., Zhou, M., Luo, J., & Xu, J.-H. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-43 · Cited by 35
The p53 isoform delta133p53ß regulates cancer cell apoptosis in a RhoB-dependent manner
Arsic, N., Ho-Pun-Cheung, A., Lopez‐Crapez, E., Assénat, E., Jarlier, M., Anguille, C., Manon, C., Mikaël, P., Roux, P., & Gadéa, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172125 · Cited by 34
Clinical and pathological aspects of condyloma acuminatum – review of literature and case presentation
Diţescu, D., Istrate-Ofiţeru, A.-M., Roşu, G. C., Iovan, L., Liliac, I. M., Zorilă, G. L., Bălăşoiu, M., & Cercelaru, L. (2022) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.62.2.03 · Cited by 42
A dominant negative form of p63 inhibits apoptosis in a p53-independent manner
Lee, H., Lee, J.-H., Choi, E., Seol, J. Y., Yun, Y., & Lee, H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.128 · Cited by 32
Molecular dynamics of the full-length p53 monomer
Chillemi, G., Davidovich, P. B., D’Abramo, M., Mametnabiev, T. E., Garabadzhiu, A. V., Desideri, A., & Melino, G. (2013) · Cell Cycle · doi:10.4161/cc.26162 · Cited by 31
The RNA helicase p68 modulates expression and function of the Δ133 isoform(s) of p53, and is inversely associated with Δ133p53 expression in breast cancer
Moore, H. C., Jordan, L. B., Bray, S. E., Baker, L., Quinlan, P., Purdie, C. A., Thompson, A. M., Bourdon, J., & Fuller-Pace, F. V. (2010) · Oncogene · doi:10.1038/onc.2010.381 · Cited by 33
Self-citation
Lovastatin causes FaDu hypopharyngeal carcinoma cell death via AMPK-p63-survivin signaling cascade
Yen, C.-S., Chen, J., Chang, Y.-F., Hsu, Y.-F., Chiu, P.-T., Shiue, C., Chuang, Y., Ou, G., & Hsu, M. (2016) · Scientific Reports · doi:10.1038/srep25082 · Cited by 31
Altered mammary gland development in the p53+/m mouse, a model of accelerated aging
Gatza, C. E., Dumble, M. L., Kittrell, F. S., Edwards, D. G., Dearth, R. K., Lee, A. V., Xu, J., Medina, D., & Donehower, L. A. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.10.004 · Cited by 32
Modulation of alternative splicing contributes to cancer development: focusing on p53 isoforms, p53β and p53γ
Solomon, H., Sharon, M., & Rotter, V. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.99 · Cited by 31
Overexpression of p53 protein in human tumors
Inoue, K., Kurabayashi, A., Shuin, T., Ohtsuki, Y., & Furihata, M. (2012) · Medical Molecular Morphology · doi:10.1007/s00795-012-0575-6 · Cited by 29
Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers
Bischof, K., Knappskog, S., Hjelle, S. M., Stefansson, I. M., Woie, K., Salvesen, H. B., Gjertsen, B. T., & Bjørge, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-41706-z · Cited by 32
Intronic TP53 Polymorphisms Are Associated with Increased Δ133TP53 Transcript, Immune Infiltration and Cancer Risk
Eiholzer, R. A., Mehta, S. Y., Kazantseva, M., Drummond, C. J., McKinney, C., Young, K., Slater, D., Morten, B. C., Avery‐Kiejda, K. A., Lasham, A., et al. (2020) · Cancers · doi:10.3390/cancers12092472 · Cited by 29
Alternative RNA Splicing—The Trojan Horse of Cancer Cells in Chemotherapy
Mehterov, N. H., Kazakova, M., Sbirkov, Y., Vladimirov, B., Belev, N., Yaneva, G. A., Todorova, K. O., Hayrabedyan, S., & Sarafian, V. S. (2021) · Genes · doi:10.3390/genes12071085 · Cited by 31
Oral lichen planus and the p53 family: what do we know?
Ebrahimi, M., Nylander, K., & van der Waal, I. (2010) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2010.00979.x · Cited by 30
Correlation analysis of two-dimensional gel electrophoretic protein patterns and biological variables
Belle, W. V., Ånensen, N., Haaland, I., Bruserud, Ø., Høgda, K., & Gjertsen, B. T. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-198 · Cited by 30
The metallothionein gene from the white shrimp Litopenaeus vannamei : Characterization and expression in response to hypoxia
Félix-Portillo, M., Martínez-Quintana, J. A., Peregrino-Uriarte, A. B., & Yepiz-Plascencia, G. M. (2014) · Marine Environmental Research · doi:10.1016/j.marenvres.2014.09.005 · Cited by 29
SCFβTrCP1 Activates and Ubiquitylates TAp63γ
Gallegos, J. R., Litersky, J. M., Lee, H., Sun, Y., Nakayama, K., Nakayama, K., & Lu, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704686200 · Cited by 29
Three birds with one stone
Toledo, F., & Bardot, B. (2009) · Nature · doi:10.1038/460466a · Cited by 29
Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL
Leeman, J. R., Weniger, M. A., Barth, T. F. E., & Gilmore, T. D. (2008) · Oncogene · doi:10.1038/onc.2008.284 · Cited by 29
Identification of DeltaN Isoform and Polyadenylation Site Choice Variants in Molluscan p63/p73-Like Homologues
Muttray, A. F., Cox, R. L., Reinisch, C. L., & Baldwin, S. A. (2007) · Marine Biotechnology · doi:10.1007/s10126-006-6045-1 · Cited by 29
Expression profiles of p53/p73, NME and GLI families in metastatic melanoma tissue and cell lines
Ozretić, P., Hanžić, N., Proust, B. L. J., Sabol, M., Trnski, D., Radić, M., Musani, V., Ciribilli, Y., Milas, I., Puljiz, Z., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48882-y · Cited by 28
The role of truncated p53 isoforms in the DNA damage response
Reinhardt, L. S., Groen, K., Newton, C., & Avery‐Kiejda, K. A. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188882 · Cited by 31
The function of Drosophila p53 isoforms in apoptosis
Zhang, B., Rotelli, M. D., Dixon, M. J., & Calvi, B. R. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.40 · Cited by 28
Deregulation of cyclin E meets dysfunction in p53: Closing the escape hatch on breast cancer
Barton, M. C., Akli, S., & Keyomarsi, K. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20818 · Cited by 28
The role of tumor protein 53 mutations in common human cancers and targeting the murine double minute 2-p53 interaction for cancer therapy.
Hamzehloie, T., Mojarrad, M., Nazarabadi, M. H., & Shekouhi, S. (2012) · Europe PMC (PubMed Central) · Cited by 28
Discussion of some ‘knowns’ and some ‘unknowns’ about the tumour suppressor p53
Lieschke, E., Wang, Z., Kelly, G. L., & Strasser, A. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy077 · Cited by 29
p53 coordinates with Δ133p53 isoform to promote cell survival under low-level oxidative stress
Gong, L., Pan, X., Yuan, Z.-M., Peng, J., & Chen, J. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv069 · Cited by 27
Regulation of p53 by E3s
Pan, M., & Blattner, C. (2021) · Cancers · doi:10.3390/cancers13040745 · Cited by 27
Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells—Relevance for Understanding (Germ Cell) Tumorigenesis
Timmerman, D. M., Remmers, T. L., Hillenius, S., & Looijenga, L. H. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105377 · Cited by 26
Expression of p53 protein isoforms predicts survival in patients with multiple myeloma
Rojas, E. A., Corchete, L. A., Ramón, C. D., Krzemiński, P., Quwaider, D., García‐Sánz, R., Martínez‐López, J., Oriol, A., Rosiñol, L., Bladé, J., et al. (2022) · American Journal of Hematology · doi:10.1002/ajh.26507 · Cited by 27
Self-citation
Alpha-Enolase Is Upregulated on the Cell Surface and Responds to Plasminogen Activation in Mice Expressing a ∆133p53α Mimic
Sawhney, S., Hood, K. A., Shaw, A., Braithwaite, A. W., Stubbs, R., Hung, N. A., Royds, J. A., & Slatter, T. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116270 · Cited by 27
Drosophila p53 controls Notch expression and balances apoptosis and proliferation
Simón, R., Aparicio, R., Housden, B. E., Bray, S. J., & Busturia, A. (2014) · APOPTOSIS · doi:10.1007/s10495-014-1000-5 · Cited by 29
Regulation of MMP-9 by p53 in first trimester cytotrophoblastic cells
Cohen, M., Wuillemin, C., Irion, O. P., & Bischof, P. (2008) · Human Reproduction · doi:10.1093/humrep/den264 · Cited by 27
p53 and its isoforms in DNA double-stranded break repair
Zhang, Y., Pan, W., & Chen, J. (2019) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1900167 · Cited by 28
ΔN133p53 expression levels in relation to haplotypes of the TP53 internal promoter region
Bellini, I., Pitto, L., Marini, M. G., Porcu, L., Moi, P., Garritano, S., Boldrini, L., Rainaldi, G., Fontanini, G., Chiarugi, M., et al. (2010) · Human Mutation · doi:10.1002/humu.21214 · Cited by 28
TAp63γ enhances nucleotide excision repair through transcriptional regulation of DNA repair genes
Liu, J., Lin, M., Zhang, C., Wang, D., Feng, Z., & Hu, W. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.10.016 · Cited by 33
Alternative Mechanisms of p53 Action During the Unfolded Protein Response
Fusée, L. T. S., Marı́n, M., Fåhræus, R., & López, I. (2020) · Cancers · doi:10.3390/cancers12020401 · Cited by 27
Genetic Events Inhibiting Apoptosis in Diffuse Large B Cell Lymphoma
Léveillé, E., & Johnson, N. A. (2021) · Cancers · doi:10.3390/cancers13092167 · Cited by 26
Tumor suppressor p53 modulates activity-dependent synapse strengthening, autism-like behavior and hippocampus-dependent learning
Lee, K. Y., Wang, H., Yook, Y., Rhodes, J. S., Christian, C. A., & Tsai, N. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02268-9 · Cited by 26
The Effect of Campylobacter concisus on Expression of IL-18, TNF-α and p53 in Barrett’s Cell Lines
Namin, B. M., Dallal, M. M. S., & Daryani, N. E. (2015) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.26393 · Cited by 26
Identification of two p53 isoforms from Litopenaeus vannamei and their interaction with NF-κB to induce distinct immune response
Li, H., Wang, S., Chen, Y., Lǚ, K., Yin, B., Li, S., He, J., & Li, C. (2017) · Scientific Reports · doi:10.1038/srep45821 · Cited by 25
Role of Smoking-Mediated molecular events in the genesis of oral cancers
Khowal, S., & Wajid, S. (2019) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2019.1646372 · Cited by 27
ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma
Cam, M., Gardner, H. L., Roberts, R. D., Fenger, J. M., D, D. C. G., London, C. A., & Çam, H. (2016) · Oncotarget · doi:10.18632/oncotarget.10406 · Cited by 25
SPARC-p53: The double agents of cancer
Camacho, D., Jesus, J. P., Palma, A. M., Martins, S. A., Afonso, A., Peixoto, M. L., Pelham, C. J., Moreno, E., & Gogna, R. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.05.004 · Cited by 27
p53 and p63 Proteoforms Derived from Alternative Splicing Possess Differential Seroreactivity in Colorectal Cancer with Distinct Diagnostic Ability from the Canonical Proteins
Montero‐Calle, A., Garranzo‐Asensio, M., Torrente-Rodríguez, R. M., Montiel, V. R., Poves, C. F., Dziaková, J., Sanz, R., del Arco, C. D., Pingarrón, J. M., Fernández‐Aceñero, M. J., et al. (2023) · Cancers · doi:10.3390/cancers15072102 · Cited by 25
RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53 abnormal myeloma cells independently of the p53 pathway
Surget, S., Descamps, G., Brosseau, C., Normant, V., Maïga, S., Gomez‐Bougie, P., Gouy, N., Godon, C., Béné, M. C., Moreau, P., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-437 · Cited by 25
Behind the scenes: Unravelling the molecular mechanisms of p53 target gene selectivity (Review)
Lohrum (2010) · International Journal of Oncology · doi:10.3892/ijo_00000757 · Cited by 24
p18HamletMediates Different p53-Dependent Responses to DNA Damage Inducing Agents
Lafarga, V., Cuadrado, A., & Nebreda, Á. R. (2007) · Cell Cycle · doi:10.4161/cc.6.19.4741 · Cited by 27
Tumor Susceptibility and Apoptosis Defect in a Mouse Strain Expressing a Human p53 Transgene
Dudgeon, C., Kek, C., Demidov, O. N., Saito, S., Fernandes, K., Diot, A., Bourdon, J., Lane, D. P., Appella, E., Fornace, A. J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2063 · Cited by 25
Self-citation
The p53 family inhibitor ΔNp73 interferes with multiple developmental programs
Hüttinger-Kirchhof, N., Çam, H., Griesmann, H., Hofmann, L., Beitzinger, M., & Stiewe, T. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401809 · Cited by 25
Δ133p53α Protects Human Astrocytes from Amyloid-beta Induced Senescence and Neurotoxicity
Ungerleider, K., Beck, J. A., Lissa, D., Joruiz, S. M., Horikawa, I., & Harris, C. C. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2022.06.004 · Cited by 24
Redox and Epigenetics in Human Pluripotent Stem Cells Differentiation
Giallongo, S., Řeháková, D., Raffaele, M., Re, O. L., Koutná, I., & Vinciguerra, M. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7983 · Cited by 23
Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant
Slatter, T. L., Hung, N. A., Bowie, S., Campbell, H., Rubio‐Terres, C., Speidel, D., Wilson, M., Baird, M. A., Royds, J. A., & Braithwaite, A. W. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.149 · Cited by 23

Authors: Bourdon, J.-C., Fernandes, K., Murray-Zmijewski, F., Liu, G., Diot, A., Xirodimas, D. P., Saville, M. K., & Lane, D. P.
Affiliations: University of Dundee (GB)
ORCID: Bourdon, Jean-Christophe
Fernandes, Kenneth
Liu, Geng
Xirodimas, Dimitris P.
Saville, Mark K.
Lane, David P.
Venue: Genes & Development
Publisher: Cold Spring Harbor Laboratory
Published: 2005-08-30
Volume: 19
Issue: 18
Pages: 2122-2137
ISSN: 0890-9369 (ISSN-L)
1549-5477
DOI: 10.1101/gad.1339905
PMC: PMC1221884
OpenAlex: W2155570392
Cited by: 810
References: 43
Citations by year: 2026: 19 · 2025: 30 · 2024: 26 · 2023: 30 · 2022: 25 · 2021: 37 · 2020: 29 · 2019: 28 · 2018: 41 · 2017: 27 · 2016: 40 · 2015: 27 · 2014: 49 · 2013: 38 · 2012: 48
Type: posted content
Language: en
Open access: bronze
doi.org
Locations: Genes & Development (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Discovery Research Portal (University of Dundee) (publishedVersion)
HAL (submittedVersion)
HighWire Press Open Archive (submittedVersion)
Genes
Funders: Medical Research Council
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords: p53 isoforms, alternative promoters, p73, p63, Δ133p53, dominant-negative p53, p53 transcriptional activity, breast tumors, Drosophila, apoptosis, cancer drug sensitivity
MeSH terms: Animals, Breast Neoplasms, Drosophila, Humans, Introns, Luciferases, Promoter Regions, Genetic, RNA, Messenger, Transcription, Genetic, Genetic Variation, Gene Expression Regulation, Neoplastic, Genes, p53, Tumor Suppressor Protein p53, Apoptosis, Genes, Insect, Alternative Splicing, Genes, Reporter, HT29 Cells, Evolution, Molecular, Protein Isoforms, Reverse Transcriptase Polymerase Chain Reaction, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

p53 isoforms can regulate p53 transcriptional activity

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks